Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01+0.03 (+3.30%)
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Cocrystal Pharma cash
Cash and short-term investments held at the end of each period.
Cocrystal Pharma's cash was $2.17M at Jun 30, 2026. For fiscal 2025 it was $7.03M, down 28.8% from the year before. Over ten years it grew -2.7% a year on average. The highest annual figure on record is $58.71M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.03M | -28.8% |
| FY2024 | Dec 31, 2024 | $9.86M | -62.6% |
| FY2023 | Dec 31, 2023 | $26.35M | -29.1% |
| FY2022 | Dec 31, 2022 | $37.14M | -36.7% |
| FY2021 | Dec 31, 2021 | $58.71M | +77.8% |
| FY2020 | Dec 31, 2020 | $33.01M | +345.0% |
| FY2019 | Dec 31, 2019 | $7.42M | +172.4% |
| FY2018 | Dec 31, 2018 | $2.72M | +264.0% |
| FY2017 | Dec 31, 2017 | $748.00K | -79.5% |
| FY2016 | Dec 31, 2016 | $3.64M | -60.8% |
| FY2015 | Dec 31, 2015 | $9.28M | +56.0% |
| FY2014 | Dec 31, 2014 | $5.95M | +475.0% |
| FY2013 | Dec 31, 2013 | $1.03M | -78.1% |
| FY2012 | Dec 31, 2012 | $4.72M | +13236.9% |
| FY2011 | Dec 31, 2011 | $35.37K | -85.9% |
| FY2010 | Dec 31, 2010 | $251.48K | -57.2% |
| FY2009 | Dec 31, 2009 | $587.41K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.17M | -54.5% |
| Q1 FY2026 | Mar 31, 2026 | $4.69M | -32.3% |
| Q4 FY2025 | Dec 31, 2025 | $7.03M | -28.8% |
| Q3 FY2025 | Sep 30, 2025 | $7.73M | -40.6% |
| Q2 FY2025 | Jun 30, 2025 | $4.77M | -73.7% |
| Q1 FY2025 | Mar 31, 2025 | $6.92M | -68.3% |
| Q4 FY2024 | Dec 31, 2024 | $9.86M | -62.6% |
| Q3 FY2024 | Sep 30, 2024 | $13.02M | -56.2% |
| Q2 FY2024 | Jun 30, 2024 | $18.14M | -44.0% |
| Q1 FY2024 | Mar 31, 2024 | $21.84M | -35.7% |
| Q4 FY2023 | Dec 31, 2023 | $26.35M | -29.1% |
| Q3 FY2023 | Sep 30, 2023 | $29.74M | -29.3% |
| Q2 FY2023 | Jun 30, 2023 | $32.42M | -36.5% |
| Q1 FY2023 | Mar 31, 2023 | $33.98M | -38.0% |
| Q4 FY2022 | Dec 31, 2022 | $37.14M | -36.7% |
| Q3 FY2022 | Sep 30, 2022 | $42.06M | -31.8% |
| Q2 FY2022 | Jun 30, 2022 | $51.03M | -23.9% |
| Q1 FY2022 | Mar 31, 2022 | $54.79M | +64.6% |
| Q4 FY2021 | Dec 31, 2021 | $58.71M | +77.8% |
| Q3 FY2021 | Sep 30, 2021 | $61.64M | +94.0% |
| Q2 FY2021 | Jun 30, 2021 | $67.06M | +247.2% |
| Q1 FY2021 | Mar 31, 2021 | $33.28M | +53.5% |
| Q4 FY2020 | Dec 31, 2020 | $33.01M | +345.0% |
| Q3 FY2020 | Sep 30, 2020 | $31.78M | +430.2% |
| Q2 FY2020 | Jun 30, 2020 | $19.32M | +158.4% |
| Q1 FY2020 | Mar 31, 2020 | $21.69M | +153.0% |
| Q4 FY2019 | Dec 31, 2019 | $7.42M | +172.4% |
| Q3 FY2019 | Sep 30, 2019 | $5.99M | +28.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.47M | +9.3% |
| Q1 FY2019 | Mar 31, 2019 | $8.57M | +586.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.72M | +264.0% |
| Q3 FY2018 | Sep 30, 2018 | $4.68M | +248.3% |
| Q2 FY2018 | Jun 30, 2018 | $6.84M | +98.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.25M | -19.7% |
| Q4 FY2017 | Dec 31, 2017 | $748.00K | -79.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.35M | -77.2% |
| Q2 FY2017 | Jun 30, 2017 | $3.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.56M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.64M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.91M | – |
See a number that looks wrong?